- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02132338
Evaluation of the Educational Program of Diabetes Mellitus: Focus on Empowerment
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In this sense, from the perspective that the routine monitoring of users with type 2 diabetes should be performed at the primary health care, which has the structural axis the family health team, and that education is fundamental to the self-management of diabetes mellitus care, applying a evaluative research based on an educational program to check before and after clinical, anthropometric data and validated instruments can provide an effective means of control and prevention of disease.
The purpose of randomization is to compare the effects and values of the dependent variables ( knowledge about diabetes mellitus, psychological attitudes, adherence to practices related to physical activity and diet self-care, empowerment for self-care in diabetes mellitus and control of clinical indicators ) in the experimental group with the group control, which are associated with the independent variable ( educational program). For the experimental group an educational systematized process, to evaluate the scope for enhancing the educational process with emphasis on Diabetes empowerment to provide self-care, thereby improving disease control will be performed. Have the control group will maintain the traditional care through individual consultations and information about the disease, through leaflets that could assist in the educational process for self-management of care. All subjects in the experimental group and the control group will be questioned in the pre -test and post - test by related instruments: (1) knowledge of the diabetes mellitus, (2) attitudes toward the psychological aspects, (3) self-care (medication adherence, diet and physical activity), (4) empowerment for self-care in diabetes mellitus and (5) clinical indicators.
Study Type
Enrollment (Actual)
Phase
- Early Phase 1
Contacts and Locations
Study Locations
-
-
Minas Gerais
-
Belo Horizonte, Minas Gerais, Brazil
- Federal University of Minas Gerais
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- users from 30 years of age diagnosed with type 2 diabetes mellitus,
- degree of education above the fourth grade of elementary education and
- ability to attend the education program.
Exclusion Criteria:
- users with reading disability and
- chronic complications (defined as kidney failure, blindness, amputation of limbs, etc.).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: The Education Health Program
Intervention forth knowledge and attitudes necessary for self-care
|
The operation of the educational program for the group under intervention will consist of groups operating with the triad of diabetes mellitus (pathophysiology of the disease, physical activity and diet), to be held in five times (cycles) approach, an interval of three months being held between them .
In each session, participants will be the same (under multidisciplinary team intervention), the content will also be the same, however, using different educational strategies.
During the intervals between cycles these users will be monitored by phone by equity and / or nursing students of the Federal University of São João Del Rei properly trained to do so.
The educational program will be developed in five times (T0, T3, T6, T9, T12) and with an interval of three months.
At every moment the educational process will be conducted with three consecutive meetings with one week interval.
In summary, 15 educational sessions with the experimental group will be held.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Glycated hemoglobin level before and after intervention
Time Frame: 1 year after start of the intervention
|
The intervention groups will be followed for 1 year.
During this period glycated hemoglobins in time 0,3,6 and 12 months will be harvested.
|
1 year after start of the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
level of knowledge about diabetes mellitus
Time Frame: 1 year after start of the intervention
|
The intervention and control groups will be followed for 1 year.
During this period glycated hemoglobins in time 0,3,6 and 12 months will be harvested.
|
1 year after start of the intervention
|
|
diabetes mellitus empowerment for self-care
Time Frame: 1 year after start of the intervention
|
The intervention and control groups will be followed for 1 year.
During this period glycated hemoglobins in time 0,3,6 and 12 months will be harvested.
|
1 year after start of the intervention
|
|
tests such as cholesterol
Time Frame: 1 year after start of the intervention
|
The intervention and control groups will be followed for 1 year.
During this period glycated hemoglobins in time 0,3,6 and 12 months will be harvested.
|
1 year after start of the intervention
|
|
tests such as fasting glucose
Time Frame: 1 year after start of the intervention
|
The intervention and control groups will be followed for 1 year.
During this period glycated hemoglobins in time 0,3,6 and 12 months will be harvested.
|
1 year after start of the intervention
|
|
body mass index
Time Frame: 1 year after start of the intervention
|
The intervention and control groups will be followed for 1 year.
During this period glycated hemoglobins in time 0,3,6 and 12 months will be harvested.
|
1 year after start of the intervention
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Loss of participants in the intervention by forfeit
Time Frame: 1 year after start of the intervention
|
1 year after start of the intervention
|
Collaborators and Investigators
Investigators
- Study Director: Heloisa Carvalho Torres, posdoctor, Federal University of Minas Gerais
- Principal Investigator: Daniel Nogueira Cortez, master, Federal University of Minas Gerais
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CAAE 22372013.2.000.5149
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes Mellitus
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
ENBIOSIS BIOTECHNOLOGIESAydin Adnan Menderes University; Izmir University of Economics; Buca Seyfi Demirsoy... and other collaboratorsNot yet recruitingType 2 Diabetes | Diabetes Mellitus Type 2Turkey (Türkiye)
-
Instituto Nacional de Ciencias Medicas y Nutricion...Active, not recruiting
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes Mellitus | Type 2 Diabetes | Type2diabetes
-
University of SalamancaUniversity of Salamanca; Instituto Piaget; Escola Superior de Tecnologia da Saúde...Enrolling by invitationType 2 Diabetes Mellitus | Aging | Hyperglycemia Due to Type 2 Diabetes MellitusPortugal
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type2Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
Kaiser PermanenteThe Permanente Medical GroupEnrolling by invitationType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes (T2D)United States
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Medical University of GrazCompletedType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes, Insulin RequiringAustria
Clinical Trials on The Education Health Program
-
Universiti Putra MalaysiaRecruiting
-
Chang Gung Memorial HospitalCompletedChronic Kidney Diseases | Acute Kidney Injury | Acute on Chronic Renal FailureTaiwan
-
Ankara UniversityCompletedEducation | Fertility | YouthTurkey
-
Suez Canal UniversityCompletedEndotracheal TubeEgypt
-
Aydin Adnan Menderes UniversityCompletedTHE HEALTH BELIEF MODEL ON THE PHYSICAL ACTIVITY BELIEFSTurkey
-
King Saud UniversityCompletedHealth Literacy | Fall Prevention | Chronic Stroke Patients | Education of Patients | Health Belief ModelSaudi Arabia
-
Ghana Health ServicesKwame Nkrumah University of Science and TechnologyNot yet recruitingSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking Behaviors
-
Children's Hospital Los AngelesJohns Hopkins University; National Institute of Diabetes and Digestive and... and other collaboratorsCompletedObesityUnited States
-
Universidad de ZaragozaRecruiting
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR)RecruitingOlder Adults | Limitation, MobilityCanada